EUVIMED · CrossrefZeitschrift
Journal of Thrombosis and Thrombolysis
ISSN 0929-5305 · Springer Science and Business Media LLC
Neueste Artikel
Prescribing of anticoagulation for atrial fibrillation in primary care
Long-term outcomes in acute coronary syndrome patients without standard modifiable risk factors: a multi-ethnic retrospective cohort study Of 5400 asian patients
Predictors of symptomatic intracranial hemorrhage after endovascular treatment for acute large vessel occlusion: data from ANGEL-ACT registry
Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes
Systemic bevacizumab as salvage therapy for persistent severe bleeding and anemia in heyde syndrome following aortic valve replacement
Incremental cost of venous thromboembolism in trauma patients with contraindications to prophylactic anticoagulation: a prospective economic study
Dual antiplatelet therapy in the contemporary drug-eluting stents era: from vulnerable stents to vulnerable patients
Thrombosis in VEXAS syndrome
The safety and efficacy of systemic versus catheter-based therapies: application of a prognostic model by a pulmonary embolism response team
Clinical outcomes of surgical embolectomy versus catheter-directed thrombolysis for acute limb ischemia: a nationwide cohort study
Antithrombosis stewardship efforts to de-escalate inappropriate combined therapy in outpatient clinics
Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes
Incidence and patient characteristics of venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer
Risk of recurrent venous thromboembolism and bleeding in patients with interstitial lung disease: a cohort study
Risk factors of thrombotic recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism
Neutrophil activation and circulating neutrophil extracellular traps are increased in venous thromboembolism patients for at least one year after the clinical event
Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
Immature platelets in patients with Covid-19: association with disease severity
Evaluation of direct thrombin inhibitors during a critical heparin shortage
A case of thrombotic thrombocytopenic purpura associated with COVID-19
Structure and function of factor X: properties, activation, and activity in prothrombinase. A retrospective in a historical context
Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeutics
Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19
Incidence and risk factors for PTT prolongation in patients receiving low-dose unfractionated heparin thromboprophylaxis
Serotonin: a platelet hormone modulating cardiovascular disease
Mitochondria-DNA copy-number and incident venous thromboembolism among middle-aged women: a population-based cohort study
Routine surveillance of pelvic and lower extremity deep vein thrombosis in stroke patients with patent foramen ovale
Functional testing of tranexamic acid effects in patients undergoing elective orthopaedic surgery
Filter clotting with continuous renal replacement therapy in COVID-19
Platelet microvesicles are associated with the severity of coronary artery disease: comparison between peripheral and coronary circulation
EUVIMED